Dr. Pat Chulada has worked in the health-related research field for over 30 years, and held diverse positions in both basic and clinical research. Dr. Chulada held a staff scientist position at the NIEHS conducting basic research developing and studying in vivo and in vivo (transgenic and knockout mice) expression models for P450 and cyclooxygenase genes. After transitioning to clinical research, she was principal investigator for several major efforts including the Head-Off Environmental Asthma in Louisiana Study, Environmental Polymorphism Registry, and the National Twin Registry Feasibility Study. Dr. Chulada subsequently moved to Westat, Inc., a large clinical research organization in Rockville MD, and took active roles for the National Children’s Vanguard Study, Population Assessment of Tobacco and Health Study, and Prostate, Lung, Colorectal, and Breast Cancer Trial. Roles included study planning and design, ethics and regulatory review, quality assurance and control, training study staff, establishing milestones and self-evaluation programs, and monitoring budgets. In these roles, she gained vast experience as a technical writer by developing diverse documents such as study grants, study proposals, statements of work, various study materials and instruments, literature reviews, technical reports, white papers, and manuscripts. She also has presented study findings at national and international meetings.
Education: B.S. in Allied Health from Merrimack College; Ph.D. in Toxicology with Genetics Minor from NC State University; Masters in Health Science – Clinical Research from Duke University